完成新冠疫苗接种对血清干扰素λ3水平的影响:单中心回顾性研究
该单中心回顾性研究分析277例住院新冠患者,比较未充分接种(0或1剂)与完成接种(≥2剂)者血清IFN-λ3水平。完成接种与IFN-λ3水平呈负相关(OR 0.94,p=0.019),且IFN-λ3阳性(≥13.6 pg/mL)可能性降低(OR 0.27,p=0.019),提示疫苗可能调节免疫应答。
要点
- 完成新冠疫苗接种与血清IFN-λ3水平降低独立相关。
- 完成接种者IFN-λ3阳性(≥13.6 pg/mL)可能性显著降低。
- 女性IFN-λ3阳性风险呈边缘性降低趋势,需进一步验证。
核心结论
- 完成新冠疫苗接种可能降低血清IFN-λ3水平,尤其抑制IFN-λ3阳性(≥13.6 pg/mL)的可能性。
研究设计与样本
- 单中心回顾性研究,纳入2022年7月至2023年3月福井综合医院277例住院新冠患者。
- 按接种状态分为未充分接种组(0或1剂,140例)和完成接种组(≥2剂,137例)。
主要发现
- logistic回归显示完成接种与血清IFN-λ3水平呈负相关(OR 0.94,p=0.019)。
- 完成接种组IFN-λ3阳性可能性降低(OR 0.27,p=0.019)。
- 线性回归中完成接种与IFN-λ3水平负相关(系数-1.715,p=0.017)。
- 女性性别与IFN-λ3阳性呈边缘性负相关(OR 0.61,p=0.067)。
- 亚组分析未发现疫苗剂次数的显著关联。
关键数值与推荐
- IFN-λ3阳性判定阈值为≥13.6 pg/mL。
- 完成接种定义为接种≥2剂新冠疫苗。
临床怎么用
- 临床可关注接种状态对IFN-λ3等免疫标志物的潜在调节作用。
- IFN-λ3或可作为评估疫苗免疫应答的参考指标,但需进一步验证。
局限性
- 单中心回顾性设计,样本量有限,因果关系受限。
- 未充分探讨疫苗剂次、接种时间及病毒变异株的影响。
- IFN-λ3与疾病严重程度的关联仍需深入研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The COVID-19 pandemic, which began in late 2019, has posed global health and economic challenges. Vaccination is crucial for reducing severe disease and hospitalization, although breakthrough infections occur. Understanding the immune response to vaccination, particularly the role of interferon lambda 3 (IFN-λ3), is essential for optimizing strategies. OBJECTIVES: This study aimed to investigate the relationship between COVID-19 vaccination status and serum IFN-λ3 levels in patients diagnosed with COVID-19. METHODS: This retrospective study analyzed 277 hospitalized COVID-19 patients admitted to Fukui General Hospital from July 2022 to March 2023. Patients were classified as insufficiently vaccinated (zero or one dose) or fully vaccinated (two or more doses). We collected demographic data, blood test results, and IFN-λ3 levels. Logistic and linear regression models were employed to analyze the impact of vaccination status on IFN-λ3 levels, with subgroup analyses assessing vaccine dose effects. RESULTS: Of 277 identified patients, 140 were in the insufficient vaccination group and 137 in the completed vaccination group. Logistic regression revealed an inverse association between serum IFN-λ3 levels and completed vaccination status (odds ratio: 0.94, p = 0.019). Reduced likelihood of IFN-λ3 positivity was noted in the completed vaccination group (odds ratio: 0.27, p = 0.019). A marginal trend was observed for female sex (odds ratio: 0.61, p = 0.067). In linear regression, completed vaccination negatively correlated with serum IFN-λ3 levels (coefficient: -1.715, p = 0.017), while age positively correlated marginally (coefficient: 0.034, p = 0.081). Subgroup analyses showed no significant associations based on vaccine dose number. CONCLUSIONS: Our findings suggest that completed COVID-19 vaccination may reduce IFN-λ3 levels, especially suppressing the likelihood of IFN-λ3 positivity (≥13.6 pg/mL), indicating a potential role of vaccines in modulating immune responses. A sex-specific effect was noted, with female sex displaying a trend toward lower IFN-λ3 levels and a significant negative association with IFN-λ3 positivity. Further research is needed to understand the relationship between IFN-λ3, vaccination status, and disease severity.
引用
- Hayashi K, Hashimoto N, Hashimoto C, et al. Effect of completed COVID-19 vaccination on serum interferon λ3: a single-center retrospective study. Vaccine. 2025. PMID: 41391390. doi:10.1016/j.vaccine.2025.128108
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。